Pharmaceutical Industry: Origin and Evolution

Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. The Pharmaceutical industry ...  Show more

The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. The Green Templeton Lectures 2009 explored the theme 'Addicted to Big Pharma? Reconcilin ...  Show more

Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health.

Together, they discuss the transformative power of drugs in changing human health—and history. They also reflect on the evolution of the drug discovery p ...

In an age where pharmacy is a global industry, stigma and medicine are now in the position where they are the co-constructors of illness on one hand and mutually exclusive players on the other. Professor Sonia Ryang (Anthropology and International Studies, University of Iowa) ext ...  Show more

This episode explores the historical shift in drug discovery from natural sources to synthetic production. 

Initially, many essential medicines like Digitalis and Aspirin were derived directly from plants, highlighting the importance of botanical resources</stron ...

China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notic ...  Show more